Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus

被引:835
作者
Nowotny, Kerstin [1 ]
Jung, Tobias [1 ]
Hoehn, Annika [1 ]
Weber, Daniela [1 ]
Grune, Tilman [1 ]
机构
[1] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Toxicol, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany
关键词
advanced glycation end products; oxidative stress; type 2 diabetes mellitus; insulin resistance; cell dysfunction; diabetic complications;
D O I
10.3390/biom5010194
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type 2 diabetes mellitus (T2DM) is a very complex and multifactorial metabolic disease characterized by insulin resistance and cell failure leading to elevated blood glucose levels. Hyperglycemia is suggested to be the main cause of diabetic complications, which not only decrease life quality and expectancy, but are also becoming a problem regarding the financial burden for health care systems. Therefore, and to counteract the continually increasing prevalence of diabetes, understanding the pathogenesis, the main risk factors, and the underlying molecular mechanisms may establish a basis for prevention and therapy. In this regard, research was performed revealing further evidence that oxidative stress has an important role in hyperglycemia-induced tissue injury as well as in early events relevant for the development of T2DM. The formation of advanced glycation end products (AGEs), a group of modified proteins and/or lipids with damaging potential, is one contributing factor. On the one hand it has been reported that AGEs increase reactive oxygen species formation and impair antioxidant systems, on the other hand the formation of some AGEs is induced per se under oxidative conditions. Thus, AGEs contribute at least partly to chronic stress conditions in diabetes. As AGEs are not only formed endogenously, but also derive from exogenous sources, i.e., food, they have been assumed as risk factors for T2DM. However, the role of AGEs in the pathogenesis of T2DM and diabetic complicationsif they are causal or simply an effectis only partly understood. This review will highlight the involvement of AGEs in the development and progression of T2DM and their role in diabetic complications.
引用
收藏
页码:194 / 222
页数:29
相关论文
共 167 条
[1]   Characterization of insulin glycation in insulin-secreting cells maintained in tissue culture [J].
AbdelWahab, YHA ;
OHarte, FPM ;
Barnett, CR ;
Flatt, PR .
JOURNAL OF ENDOCRINOLOGY, 1997, 152 (01) :59-67
[2]   Glycation of insulin in the islets of Langerhans of normal and diabetic animals [J].
AbdelWahab, YHA ;
OHarte, FPM ;
Ratcliff, H ;
McClenaghan, NH ;
Barnett, CR ;
Flatt, PR .
DIABETES, 1996, 45 (11) :1489-1496
[3]  
Abdul-Ghani Muhammad A., 2008, P191, DOI 10.1007/978-1-59745-420-9_11
[4]   N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins [J].
Ahmed, MU ;
Frye, EB ;
Degenhardt, TP ;
Thorpe, SR ;
Baynes, JW .
BIOCHEMICAL JOURNAL, 1997, 324 :565-570
[5]   N-EPSILON-CARBOXYMETHYLLYSINE FORMATION BY DIRECT ADDITION OF GLYOXAL TO LYSINE DURING THE MAILLARD REACTION [J].
ALABED, Y ;
BUCALA, R .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (18) :2161-2162
[6]   Eye vessels saved by rescuing their pericyte partners [J].
Antonetti, David .
NATURE MEDICINE, 2009, 15 (11) :1248-1249
[7]   Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes [J].
Aso, Y ;
Inukai, T ;
Tayama, K ;
Takemura, Y .
ACTA DIABETOLOGICA, 2000, 37 (02) :87-92
[8]   Determination of N E⟩-(carboxymethyl)lysine in food systems by ultra performance liquid chromatography-mass spectrometry [J].
Assar, Shima H. ;
Moloney, Catherine ;
Lima, Maria ;
Magee, Ronald ;
Ames, Jennifer M. .
AMINO ACIDS, 2009, 36 (02) :317-326
[9]   Nitric oxide and arterial disease [J].
Barbato, JE ;
Tzeng, E .
JOURNAL OF VASCULAR SURGERY, 2004, 40 (01) :187-193
[10]   ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLICATIONS IN DIABETES [J].
BAYNES, JW .
DIABETES, 1991, 40 (04) :405-412